Suchergebnisse - "García-Casado, Zaida"

PubPharm (120)

1

Clinical, histological, and molecular differences in melanoma due to different TERT promoter mutations subtypes. A retrospective cross-sectional study in 684 melanoma patients

enthalten in: Pigment cell & melanoma research | 2024

von Manrique-Silva, E. | David, M. | Maider, A. | +7

2

Molecular Profile of Subungual Melanoma : A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter Status

enthalten in: Dermatology (Basel, Switzerland) | 2024

von Millan-Esteban, D. | García-Casado, Z. | Macià, A. | +17

3

Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment : SOGUG-IMANOL Study

enthalten in: Cancers | 2023

von Juan Fita, M. | Anido Herranz, U. | Mendez-Vidal, M. | +10

4

A shared origin from a common ancestor : A case report of two histologically different tumors

enthalten in: Pathology, research and practice | 2023

von Varea-Martínez, M. | García-Valero, E. | López-Reig, R. | +9

5

Adult Pancreatoblastoma : Report of 3 new Cases With Genetic Diversity and Autopsy Findings

enthalten in: International journal of surgical pathology | 2023

von Machado, I. | López-Guerrero, J. | Fernandez, A. | +5

6

Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors : the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2023

von Garcia-Donas, J. | Hurtado, A. | Garrigos, L. | +20

7

The Scarface Score : Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer-A GEICO Study

enthalten in: Cancers | 2023

von Fernández-Serra, A. | López-Reig, R. | Márquez, R. | +21

8

Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03

enthalten in: Clinical and translational oncology | 2023

von Garcia-Donas, J. | Hurtado, A. | Garrigos, L. | +19

9

Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03

enthalten in: Revista de oncología | 2023

von Garcia-Donas, J. | Hurtado, A. | Garrigos, L. | +19

10

Editorial : Molecular genetics of cutaneous melanoma: current status and future direction-volume II

enthalten in: Frontiers in molecular biosciences | 2023

von Garcia-Casado, Z. | Pellegrini, C. | Cho, W.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]